Orthopedic medicine, joint health, and regenerative therapies by Anika Therapeutics

  • Igor Krasulya
  • 03.06.2026
Anika Therapeutics introduces proprietary Hyaff material for next generation regenerative applications
Anika Therapeutics has introduced Hyaff, a proprietary hyaluronic acid derivative developed for regenerative applications in tendon and cartilage repair. The innovation leverages over 20 years ...
  • Elena Nikulina
  • 20.05.2026
Anika Therapeutics honors Clinical Trials Day as it advances patient outcomes
Anika Therapeutics is celebrating Clinical Trials Day, recognizing the essential contributions of clinical trial teams and participants. The company emphasized that its approach to clinical ...
  • Yulia Slavina
  • 18.05.2026
Anika Therapeutics invites ESSKA Congress delegates to explore advances in HA-based cartilage repair
Anika Therapeutics is set to attend the upcoming ESSKA Congress, aiming to engage with specialists on the latest developments in cartilage restoration and tendon repair utilizing HA-based ...
  • Hlib Chabaniuk
  • 07.05.2026
Anika Therapeutics explores why skin heals rapidly but tendons and cartilage lag in recovery
Anika Therapeutics draws attention to the stark difference in healing speeds between skin and deeper musculoskeletal tissues. While skin can regenerate within days, tendons and cartilage require ...
  • Iryna Sazhynska
  • 30.04.2026
Rotator cuff procedure advances driven by biology, Anika Therapeutics claims
Anika Therapeutics has identified biological factors as the critical missing link in improving outcomes for rotator cuff repair after years of technological advancements. This development is ...
  • Artem Shendetskii
  • 27.04.2026
Anika Therapeutics ends Shoulder360 weekend by inviting demo requests for Integrity product
Anika Therapeutics has concluded its weekend participation at the Shoulder360 event, highlighting the recent exposure of its Integrity implant solution. The company is now inviting those who ...
  • Andreas Kristo
  • 23.04.2026
Integrity Implant System introduced as Anika Therapeutics opens Shoulder360 conference
Anika Therapeutics has launched its Integrity Implant System at the start of the Shoulder360 event, inviting attendees to visit its team and experience the technology firsthand at booth 35. The ...
  • Eugene Komchuk
  • 15.04.2026
Anika Therapeutics advances biologic innovation in tendon injury treatment
Anika Therapeutics presents new developments in the treatment of rotator cuff tears and tendon injuries, emphasizing the role of biologic innovation in supporting healing. The company outlines ...
  • Oleg Tkachenko
  • 09.04.2026
Anika Therapeutics partners with J&J Medtech to distribute Orthovisc and Monovisc in the U.S.
Anika Therapeutics is prioritizing pain treatment for osteoarthritis through its hyaluronic acid-based injection therapies. The company announced that Orthovisc and Monovisc are available in the ...
  • Iryna Sazhynska
  • 02.04.2026
Anika Therapeutics Integrity case study reveals advanced outcome in high-risk rotator cuff patient
Anika Therapeutics has published a new Integrity case report by Dr. Adnan Cheema and Kate Schmitz, examining a high-risk rotator cuff patient who experienced results that exceed conventional ...
  • Andrey Mastykin
  • 03.03.2026
Anika Therapeutics debuts Integrity and highlights portfolio at AAOS
Anika Therapeutics is making a strong presence at the AAOS conference this week by unveiling its Integrity product for rotator cuff repair. The company is also showcasing its advanced solutions ...
  • Eugene Komchuk
  • 27.02.2026
Anika Therapeutics showcases Integrity benefits at ACFAS conference
Anika Therapeutics expressed appreciation for the ACFAS conference, stating the event provided an opportunity to engage directly with industry professionals. The company highlighted its ...
  • Andrey Mastykin
  • 25.02.2026
Anika Therapeutics cites 40 publications and 16 years of clinical data for Hyalofast cartilage repair
Anika Therapeutics presents an extensive body of research on Hyalofast, highlighting over 40 scientific publications and 16 years of published clinical evidence supporting its use in cartilage ...
  • Ashutosh Sureka
  • 17.11.2025
Anika Therapeutics showcases regenerative medicine at MEDICA2025
Anika Therapeutics is making waves on the first day of the MEDICA2025 event, where over 5,000 exhibitors and 80,000 visitors have gathered to explore the latest in healthcare innovation and ...
  • Dmytro Kharkov
  • 16.11.2025
Anika Therapeutics leverages Hyalofast for long-term cartilage repair success
Anika Therapeutics is pioneering advancements in cartilage repair with its innovative product, Hyalofast. This breakthrough technology employs resorbable hyaluronic acid to facilitate natural ...
  • Viktoras Karapetjanc
  • 11.11.2025
Anika Therapeutics explores HA-based scaffold's impact on tendon repair
Anika Therapeutics, in collaboration with Dr. Christopher Baker and colleagues, has recently conducted research on the effectiveness of their hyaluronic acid (HA)-based scaffold for supporting ...